跳至主要内容
临床试验/CTRI/2025/08/092422
CTRI/2025/08/092422已完成2 期

A Comparative Pharmaceutico clinical study on SAVARNAKAR LEPA AND MOOLAKBEEJ AVALGUJADI LEPA and their effect on Shvitra w.s.r to VITILIGO

Dr BIJAY KUMAR JAISWAL1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2027年6月7日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
TO EVALUATE THE EFFECT OF SAVARNAKAR LEPA - MOOLAKBEEJ AVALGUJADI LEPA

研究概览

简要总结

Patient will be randomly selected based on the presence of classical symptoms of  shvitra. All the patients will be examined every 15 days during the treatment. To observe the relief in signs and symptoms of the disease Shvitra, scoring for the signs and symptoms will be done. Observation will be taken before and after the treatment.

Total 60 patients were taken for clinical trial, there was comparitive study. Savarnakr lepa was found to be more effective in the treatment of shvitra.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Selected sign and symptoms based on both ayurvedic and modern context Patients having lakshana of Shvitra as per Ayurvedic text.

排除标准

  • (a) Age group below 20 and above 70 years.
  • (b) Having complications like renal disease etc.
  • (c) Patients having any other systemic illness.
  • (d) Patient of Shvitra having secondary infection.
  • (f) Patients associated with Diabetes.
  • (g) Patients having AIDS, HeptB, Leukaemia.

结局指标

主要结局

TO EVALUATE THE EFFECT OF SAVARNAKAR LEPA - MOOLAKBEEJ AVALGUJADI LEPA

时间窗: PATIENTS WILL BE EVALUATED AFTER EVERY 15 DAYS OUT OF 90 DAYS TRAIL

次要结局

  • To study the preparation of Safe, effective, and quality drug and(standardization.)

研究者

发起方
Dr BIJAY KUMAR JAISWAL
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr BIJAY KUMAR JAISWAL

GOVERNMENT AYURVEDIC COLLEGE AND HOSPITAL PATNA BIHAR

研究点 (1)

Loading locations...

相似试验